Chennai, India

Padmapriya Ganapathy Raman

This inventor holds 1 USPTO granted patent. Top assignee: Anna University. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Padmapriya Ganapathy Raman. Retrieved from https://idiyas.com/inventor/padmapriya-ganapathy-raman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Padmapriya Ganapathy Raman

Introduction

Padmapriya Ganapathy Raman is a notable inventor based in Chennai, India. She has made significant contributions to the field of biochemistry, particularly in the production of key drug intermediates. Her work focuses on innovative methods that utilize genetically engineered strains for biotransformation processes.

Latest Patents

One of her most recent patents is titled "Production of L-2-aminobutyrate from citramalate, citraconate or 2-oxobutanoate." This invention relates to the preparation of L-2-amino butyric acid (L-2-ABA) through a cell-free system. The method employs biotransformation using genetically engineered strains and economically available substrates like citramalate or citraconate, along with specific enzymes such as LeuCD, LeuB, and ValDH or IlvE. She holds 1 patent for this innovative work.

Career Highlights

Padmapriya is affiliated with Anna University, where she contributes to research and development in her field. Her academic and professional journey reflects her dedication to advancing biotechnological applications.

Collaborations

She has collaborated with notable coworkers, including Akila Thirumalai and Nikhil Sangith, to further her research initiatives.

Conclusion

Padmapriya Ganapathy Raman's innovative work in biochemistry exemplifies the impact of scientific research on drug development. Her contributions are paving the way for advancements in the production of essential drug intermediates.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…